1. Alessandrini, A., Chiaur, D.S., and Pagano, M., 1997, Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation, Leukemia 11:342–345.
2. Bates, S., Bonetta, L., MacAllan, D., Parry, D., Holder, A., Dickson, C., and Peters, G., 1994, CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1, Oncogene 9:71–79.
3. Bouffler, S.D., Kemp, C.J., Balmain, A., and Cox, R., 1995, Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice, Cancer Res 55:3883–3889.
4. Chen, E., and Li, C.C., 1998, Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase, Biochem Biophys Res Comm 249:728–734.
5. Chen, J., Jackson, P.K., Kirschner, M.W., and Dutta, A., 1995, Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA, Nature 374:386–388.